Survival after organ preserving treatment for T4a laryngeal squamous cell carcinoma

Annals of Oncology

Volumn 21, Issue 11, 2010, Pages 2292-2293

  Hamdan, J ^a   Feldman, L ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; HUMAN; LARYNGECTOMY; LARYNX TUMOR; LETTER; ORGAN PRESERVATION; OVERALL SURVIVAL; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME; TUMOR VOLUME;

CARCINOMA, SQUAMOUS CELL; HUMANS; LARYNGEAL NEOPLASMS; NEOPLASM STAGING; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77958500364     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdq562     Document Type: Letter

References (4)

1. Knab BR et al. Functional organ preservation with definitive chemoradiotherapy for T4 laryngeal squamous cell carcinoma. Ann Oncol 2008; 19: 1650-1654.
2. Forastiere AA, Goepfert H, Maor M et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003; 349: 2091-2098.
3. The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991; 324: 1685-1690.
4. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence-SEER 9 Regs Limited-Use, Nov 2007 Sub (1973-2005) -Linked To County Attributes-Total U.S., 1969-2005 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2010 www.seer.cancer.gov (14 September 2010, date last accessed).